CREB3L1 and breast carcinoma: The TNBC cell lines displayed relatively lower baseline levels of CREB3L1 than the others, consistent with previous findings of frequently upregulated CREB3L1 in ER positive and HER2-neu positive breast cancers, but not in TNBC (29).